Blog
126 Articles

Report Highlights Potential of TCR Therapy
Read about the potential of TCR therapy, a technique used with success for one pancreatic cancer patient in a groundbreaking immunotherapy clinical trial.

A New Immunotherapy Combination for Metastatic Pancreatic Cancer
Researchers are looking at a combination of two types of monoclonal antibodies to treat advanced pancreatic cancer.

2022 AACR Annual Meeting Update
The 2022 AACR Annual Meeting featured the latest in pancreatic cancer breakthroughs, research in artificial intelligence, screening, detection, and vaccines.

New Immunotherapy Strategy Aimed at High-Risk Population
Dr. Neeha Zaidi is the lead investigator of an immunotherapy trial using a vaccine for people at high risk for pancreatic cancer.

A Report from ASCO GI 2022
Clinical trials were reported on at ASCO GI 2022, as well as reports on COVID, virtual tumor boards, and racial disparities in treatment.

Pancreatic Cancer Science—2021 in Review
As the year winds down Let’s Win provides an overall look at the highlights of 2021 in pancreatic cancer science.

A Vaccine To Boost Immune Response to Pancreatic Cancer
Researchers are testing whether a vaccine can heighten the body’s immune response to pancreatic cancer after surgical removal of the tumor.

Triple Immunotherapy Shows Dramatic Results
Dr. William Freed-Pastor is testing a combination of three types of immunotherapy to attack pancreatic tumors.